Prickly pear Opuntia ficus-indica (L.) Mill.
Also called: cactus pear, opuntia, nopal (cladode)
Opuntia ficus-indica is a cactus native to Mexico whose flowers, flat stem pads (cladodes, eaten as nopal) and fruits (prickly pears) are consumed raw or processed. Research separates fruit from cladode products, which differ in composition, including fiber.
- Category
- Botanical
- Part used
- Fruit (prickly pear or cactus pear) and cladode (stem pad, nopal), including cladode fiber and extracts
- Strongest evidence
- B Some positive trials
- Native range
- Native to Mexico (POWO: "Mexico (Oaxaca)"; listed as introduced in many regions worldwide)
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2015 systematic review and meta-analysis of randomized clinical trials of cactus pear (Opuntia ficus-indica) supplementation identified seven eligible studies and included five; the abstract does not state how many trials each pooled outcome used. [1]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels2 topics
CBlood sugar and weight2 topics
CStomach and gut1 topic
CSeveral areas, whole body or blood1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Body weight in adults | C | A 2015 meta-analysis of five RCTs found no significant difference in body weight between Opuntia ficus-indica and controls (mean difference -0.83 kg, 95% CI -2.49 to 0.83); trials varied in design and reporting quality. [1] |
| Body fat, blood pressure and total cholesterol | B | The 2015 Onakpoya meta-analysis reported significant reductions in body mass index, percentage body fat, systolic and diastolic blood pressure and total cholesterol, but few trials had been published and their quality was inconsistent. [1] |
| Blood lipids, fruit versus cladode | C | A 2020 systematic review of 11 studies found prickly pear fruit was associated with significant total-cholesterol reductions in all but one study, while cladode effects on lipids were small. [3] |
| Blood glucose and insulin, fruit versus cladode | C | A 2019 systematic review of 20 human studies found cladode and some Opuntia products mostly reduced glucose and insulin, while the fruit mostly had no significant effect; fruit and cladode studies had high risk of bias. [2] |
| Irritable bowel syndrome symptoms (nopal fiber) | C | A one-week RCT in 60 people with IBS found more reported adequate relief with 20 g/day (87%) and 30 g/day (80%) nopal fiber than placebo (33%); 30 g/day caused more loose stools. [4] |
| Alcohol hangover symptoms | C | In a crossover RCT (64 young adults randomized, 55 completed), an Opuntia extract taken before drinking reduced nausea, dry mouth and anorexia; the overall symptom index fell 2.7 points (P = .07). [5] |
Main constituents: High levels of bioactive phytochemicals, in particular betalains [6]; Dietary fiber: the fruit is rich in fiber, and fiber composition is cited as a difference between fruit and cladode [3]; Nopal (cladode) fiber contains both insoluble and soluble fibers [4]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Nopal fiber 10, 20 or 30 g/day for one week (IBS trial). [4]
- Opuntia ficus-indica extract 1600 IU, taken once 5 hours before alcohol (hangover trial). [5]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
Identity, quality and standardization
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming prickly pear, cactus pear, nopal or Opuntia ficus-indica was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P4]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of prickly pear (Opuntia ficus-indica) was found (IARC Monographs list of classifications, Volumes 1–142, and NTP technical reports checked 2026-10-29). [P5]
- The NTP Technical Reports index (TR-001 to TR-606) lists no study of Opuntia or prickly pear (checked 2026-10-29). [P6]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- In a placebo-controlled crossover RCT (64 young adults randomized, 55 completed) in which participants drank up to 1.75 g alcohol/kg, an Opuntia ficus-indica extract taken 5 hours before drinking reduced next-morning nausea, dry mouth and anorexia; the abstract reports no interaction data. [P9]
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P7]
- Plant-part identity: fruit versus cladode (stem pad) — A 2020 systematic review reports that prickly pear fruit is often confused with the cladode, or not identified, and that the two differ in composition, including fiber. [P3]
Supply and conservation
- IUCN Red List: Data Deficient (DD), via GBIF species API, retrieved 2026-10-29. [P8]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Cheok A, et al. The effects of betalain-rich cacti (dragon fruit and cactus pear) on endothelial and vascular function: a systematic review of animal and human studies. Food Funct 2020;11(8):6807-6817 (PMID 32716446), 2020-08. pubmed.ncbi.nlm.nih.gov
- Remes-Troche JM, et al. Nopal fiber (Opuntia ficus-indica) improves symptoms in irritable bowel syndrome in the short term: a randomized controlled trial. Neurogastroenterol Motil 2021;33(2):e13986 (PMID 32935904), 2021-02. pubmed.ncbi.nlm.nih.gov
- Gouws C, et al. The effects of prickly pear fruit and cladode (Opuntia spp.) consumption on blood lipids: a systematic review. Complement Ther Med 2020;50:102384 (PMID 32444049), 2020-05. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications, Volumes 1–142 (retrieved 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; retrieved 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Opuntia ficus-indica (L.) Mill., 2026-10-29. api.gbif.org
- Wiese J, et al. Effect of Opuntia ficus indica on symptoms of the alcohol hangover. Arch Intern Med 2004;164(12):1334-1340 (PMID 15226168), 2004-06. pubmed.ncbi.nlm.nih.gov
Sources
- Onakpoya IJ, O'Sullivan J, Heneghan CJ. The effect of cactus pear (Opuntia ficus-indica) on body weight and cardiovascular risk factors: a systematic review and meta-analysis of randomized clinical trials. Nutrition 2015;31(5):640-646 (PMID 25837206), 2015-05. pubmed.ncbi.nlm.nih.gov
- Gouws CA, et al. Effects of the consumption of prickly pear cacti (Opuntia spp.) and its products on blood glucose levels and insulin: a systematic review. Medicina (Kaunas) 2019;55(5):138 (PMID 31096667), 2019-05. pubmed.ncbi.nlm.nih.gov
- Gouws C, et al. The effects of prickly pear fruit and cladode (Opuntia spp.) consumption on blood lipids: a systematic review. Complement Ther Med 2020;50:102384 (PMID 32444049), 2020-05. pubmed.ncbi.nlm.nih.gov
- Remes-Troche JM, et al. Nopal fiber (Opuntia ficus-indica) improves symptoms in irritable bowel syndrome in the short term: a randomized controlled trial. Neurogastroenterol Motil 2021;33(2):e13986 (PMID 32935904), 2021-02. pubmed.ncbi.nlm.nih.gov
- Wiese J, et al. Effect of Opuntia ficus indica on symptoms of the alcohol hangover. Arch Intern Med 2004;164(12):1334-1340 (PMID 15226168), 2004-06. pubmed.ncbi.nlm.nih.gov
- Cheok A, et al. The effects of betalain-rich cacti (dragon fruit and cactus pear) on endothelial and vascular function: a systematic review of animal and human studies. Food Funct 2020;11(8):6807-6817 (PMID 32716446), 2020-08. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Opuntia ficus-indica (L.) Mill. (accessed 2026-10-29; native range: "Mexico (Oaxaca)"), 2026-10-29. powo.science.kew.org
- Giraldo-Silva L, et al. Opuntia ficus-indica fruit: a systematic review of its phytochemicals and pharmacological activities. Plants (Basel) 2023;12(3):543 (PMID 36771630), 2023-01. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.